Study of the factors related to air-bone gap in enlarged vestibular aqueduct.


Journal

Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354

Informations de publication

Date de publication:
Jan 2024
Historique:
medline: 18 3 2024
pubmed: 30 1 2024
entrez: 30 1 2024
Statut: ppublish

Résumé

Over half of patients with enlarged vestibular aqueducts (EVA) will have an air-bonr gap (ABG), however, current research on audiology has focused on the influencing factors of air-conducted. To retrospectively analyse the influencing factors and clinical manifestations of the bone-conduction threshold and ABG in patients with EVA. We included 286 patients with EVA; among them, 126 had full Among 555 ears, 312 (57.8%) ears had ABG; approximately 94% of the patients' bone-conduction hearing is almost completely lost at frequencies of 2 and 4 kHz. There was no linear correlation between age and bone-conduction threshold ( Among patients with EVA, ABG is mainly produced at low frequencies and is not significantly correlated with age, size of the VA opening or

Sections du résumé

BACKGROUND UNASSIGNED
Over half of patients with enlarged vestibular aqueducts (EVA) will have an air-bonr gap (ABG), however, current research on audiology has focused on the influencing factors of air-conducted.
OBJECTIVE UNASSIGNED
To retrospectively analyse the influencing factors and clinical manifestations of the bone-conduction threshold and ABG in patients with EVA.
MATERIALS AND METHODS UNASSIGNED
We included 286 patients with EVA; among them, 126 had full
RESULTS UNASSIGNED
Among 555 ears, 312 (57.8%) ears had ABG; approximately 94% of the patients' bone-conduction hearing is almost completely lost at frequencies of 2 and 4 kHz. There was no linear correlation between age and bone-conduction threshold (
CONCLUSIONS AND SIGNIFICANCE UNASSIGNED
Among patients with EVA, ABG is mainly produced at low frequencies and is not significantly correlated with age, size of the VA opening or

Identifiants

pubmed: 38289678
doi: 10.1080/00016489.2024.2308014
doi:

Substances chimiques

Membrane Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-43

Auteurs

Rong Wang (R)

The First Affiliated Hospital of Fujian Medical University, Fuzhou, PR China.
Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, PR China.
National Key Laboratory of Hearing and Balance Science, Beijing, PR China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, PR China.
Beijing Key Lab of Hearing Impairment Prevention and Treatment, Beijing, PR China.

Bo-Xiang Zhuang (BX)

Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, PR China.
National Key Laboratory of Hearing and Balance Science, Beijing, PR China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, PR China.
Beijing Key Lab of Hearing Impairment Prevention and Treatment, Beijing, PR China.

Weiwei Guo (W)

Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, PR China.
National Key Laboratory of Hearing and Balance Science, Beijing, PR China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, PR China.

Jianan Li (J)

Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, PR China.
National Key Laboratory of Hearing and Balance Science, Beijing, PR China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, PR China.
Beijing Key Lab of Hearing Impairment Prevention and Treatment, Beijing, PR China.

Chang Lin (C)

The First Affiliated Hospital of Fujian Medical University, Fuzhou, PR China.

Shiming Yang (S)

Department of Otolaryngology-Head and Neck Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, PR China.
National Key Laboratory of Hearing and Balance Science, Beijing, PR China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, PR China.
Beijing Key Lab of Hearing Impairment Prevention and Treatment, Beijing, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH